A randomized clinical trial to evaluate the effects of rasagiline on depressive symptoms in non-demented Parkinson's disease patients

Combined Rasagiline and Antidepressant Use in Parkinson Disease in the ADAGIO Study

(2015) Kara M. Smith et al.   JAMA Neurology

Rasagiline: A Review of Its Use in the Treatment of Idiopathic Parkinson’s Disease

(2014) Paul L. McCormack   CNS DRUGS

Effects of rasagiline on the progression of nonmotor scores of the MDS-UPDRS

(2014) Werner Poewe et al.   MOVEMENT DISORDERS

Mild cognitive impairment in Parkinson's disease

(2013) A. J. Yarnall et al.   AGE AND AGEING

Nonmotor fluctuations in Parkinson disease: Severity and correlation with motor complications

(2013) A. Storch et al.   NEUROLOGY

A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease

(2012) I. H. Richard et al.   NEUROLOGY

A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes

(2011) Olivier Rascol et al.   LANCET NEUROLOGY

The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: A randomized, double-blind, placebo-controlled, multicenter study

(2011) Hasmet A. Hanagasi et al.   MOVEMENT DISORDERS

Parkinson's disease: The quintessential neuropsychiatric disorder

(2011) Daniel Weintraub et al.   MOVEMENT DISORDERS

Binding of Pramipexole to Extrastriatal Dopamine D2/D3 Receptors in the Human Brain: A Positron Emission Tomography Study Using 11C-FLB 457

(2011) Kenji Ishibashi et al.   PLoS One

Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial

(2010) Paolo Barone et al.   LANCET NEUROLOGY

A controlled trial of antidepressants in patients with Parkinson disease and depression

(2008) M. Menza et al.   NEUROLOGY